1
TITLE: Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy  Full Text
AUTHORS: Patricia Severino; Marcelo Szymanski; Marianna Favaro; Adriano R Azzoni; Marco V Chaud; Maria Helena A Santana; Amelia M Silva; Eliana B Souto ;
SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 66, PUBLISHED: 2015
INDEXED IN: Scopus WOS CrossRef
2
TITLE: Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy
AUTHORS: Severino, P; Szymanski, M; Favaro, M; Azzoni, AR; Chaud, MV; Santana, MHA; Silva, AM; Souto, EB;
SOURCE: European Journal of Pharmaceutical Sciences, VOLUME: 66, PUBLISHED: 2014
INDEXED IN: Scopus
3
TITLE: Impact of Plasmid Quality on Lipoplex-Mediated Transfection  Full Text
AUTHORS: Jonathan De La Vega; Bas Ter Braak; Adriano R Azzoni; Gabriel A Monteiro ; Duarte Miguel F Prazeres ;
SOURCE: JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 102, ISSUE: 11, PUBLISHED: 2013
INDEXED IN: Scopus WOS CrossRef
4
TITLE: Development of a recombinant fusion protein based on the dynein light chain LC8 for non-viral gene delivery  Full Text
AUTHORS: Marcelo A S Toledo; Richard Janissen; Marianna T P Favaro; Monica A Cotta; Gabriel A Monteiro ; Duarte Miguel F Prazeres ; Anete P Souza; Adriano R Azzoni;
SOURCE: JOURNAL OF CONTROLLED RELEASE, VOLUME: 159, ISSUE: 2, PUBLISHED: 2012
INDEXED IN: Scopus WOS CrossRef
6
TITLE: Comparative Analysis of Antigen-Targeting Sequences Used in DNA Vaccines  Full Text
AUTHORS: Joana A Carvalho; Adriano R Azzoni; Duarte M F Prazeres ; Gabriel A Monteiro ;
SOURCE: MOLECULAR BIOTECHNOLOGY, VOLUME: 44, ISSUE: 3, PUBLISHED: 2010
INDEXED IN: Scopus WOS
7
TITLE: Erratum to: Comparative Analysis of Antigen-Targeting Sequences Used in DNA Vaccines  Full Text
AUTHORS: Joana A Carvalho; Adriano R Azzoni; Duarte M F Prazeres; Gabriel A Monteiro;
SOURCE: Molecular Biotechnology - Mol Biotechnol, VOLUME: 47, ISSUE: 1, PUBLISHED: 2010
INDEXED IN: CrossRef
8
TITLE: Comparative Analysis of Antigen-Targeting Sequences Used in DNA Vaccines  Full Text
AUTHORS: Joana A Carvalho; Adriano R Azzoni; Duarte M F Prazeres; Gabriel A Monteiro;
SOURCE: Molecular Biotechnology - Mol Biotechnol, VOLUME: 44, ISSUE: 3, PUBLISHED: 2009
INDEXED IN: CrossRef
9
TITLE: Replacement of nuclease labile sequences in the origin of replication of plasmid vectors can significantly improve transgene expression
AUTHORS: Adriano R Azzoni; Jorge Beira; Duarte M F Prazeres; Gabriel A Monteiro ;
SOURCE: 15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy in HUMAN GENE THERAPY, VOLUME: 18, ISSUE: 10, PUBLISHED: 2007
INDEXED IN: WOS
10
TITLE: Gene delivery using non-viral vectors: Trace impurities in plasmid DNA preparations can strongly affect transfection of mammalian cells
AUTHORS: Adriano R Azzoni; Ming L Wu; Sindelia S Freitas; Gabriel A Monteiro ; Duarte M F Prazeres;
SOURCE: 15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy in HUMAN GENE THERAPY, VOLUME: 18, ISSUE: 10, PUBLISHED: 2007
INDEXED IN: WOS
Page 1 of 2. Total results: 16.